Peregrine Capital Management’s Edwards Lifesciences EW Stock Holding History

Peregrine Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-405,261	Closed	-$26.7M	–	341
2024 Q3	$26.7M	Sell	405,261 -3,888	-1%	-$282K	0.81%	24
2024 Q2	$37.8M	Buy	409,149 +8,076	+2%	+$715K	1.1%	19
2024 Q1	$38.3M	Sell	401,073 -6,756	-2%	-$568K	1.1%	19
2023 Q4	$31.1M	Sell	407,829 -15,814	-4%	-$1.1M	0.93%	24
2023 Q3	$29.3M	Buy	423,643 +112	+0%	+$9K	0.88%	23
2023 Q2	$40M	Sell	423,531 -4,675	-1%	-$406K	1.09%	18
2023 Q1	$35.4M	Buy	428,206 +5,122	+1%	+$403K	1.02%	17
2022 Q4	$31.6M	Buy	423,084 +6,485	+2%	+$500K	0.99%	14
2022 Q3	$34.4M	Sell	416,599 -5,789	-1%	-$557K	1.11%	12
2022 Q2	$40.2M	Sell	422,388 -25,467	-6%	-$2.64M	1.21%	9
2022 Q1	$52.7M	Sell	447,855 -37,938	-8%	-$4.26M	1.25%	10
2021 Q4	$62.9M	Buy	485,793 +41,643	+9%	+$4.86M	1.26%	15
2021 Q3	$50.3M	Sell	444,150 -3,428	-0.8%	-$391K	1.04%	19
2021 Q2	$46.4M	Buy	447,578 +20,564	+5%	+$1.94M	0.83%	23
2021 Q1	$35.7M	Buy	427,014 +29,871	+8%	+$2.53M	0.66%	28
2020 Q4	$36.2M	Buy	397,143 +50,687	+15%	+$4.2M	0.69%	32
2020 Q3	$27.7M	Buy	346,456 +70,823	+26%	+$5.53M	0.73%	31
2020 Q2	$19M	Buy	275,633 +8,747	+3%	+$622K	0.54%	62
2020 Q1	$16.8M	Buy	266,886 +2,091	+0.8%	+$151K	0.6%	58
2019 Q4	$20.6M	Buy	264,795 +993	+0.4%	+$77.5K	0.52%	67
2019 Q3	$19.3M	Sell	263,802 -50,772	-16%	-$3.57M	0.53%	76
2019 Q2	$19.4M	Hold	314,574	–	–	0.48%	82
2019 Q1	$20.1M	Buy	314,574 +3,720	+1%	+$212K	0.5%	75
2018 Q4	$15.9M	Buy	310,854 +7,740	+3%	+$392K	0.45%	90
2018 Q3	$17.6M	Hold	303,114	–	–	0.42%	110
2018 Q2	$14.7M	Buy	303,114 +990	+0.3%	+$46.2K	0.37%	123
2018 Q1	$14.1M	Sell	302,124 -1,134	-0.4%	-$49.2K	0.34%	121
2017 Q4	$11.4M	Hold	303,258	–	–	0.27%	145
2017 Q3	$11.1M	Hold	303,258	–	–	0.27%	154
2017 Q2	$12M	Hold	303,258	–	–	0.3%	138
2017 Q1	$9.54M	Sell	303,258 -97,143	-24%	-$3.04M	0.24%	175
2016 Q4	$12.5M	Buy	+400,401	New	+$13M	0.32%	122